Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Frontiers in Oncology
|
May 19, 2023
Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy
Ruoxin Fang, Ling Yan, Zhengkai Liao
Frontiers in Oncology
|
August 7, 2023
An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAF<sup>V600E</sup> mutation responds to dabrafenib and trametinib: a case report and literature review
Ruoxin Fang, Jun Gong, Zhengkai Liao
Oncotargets and Therapy
|
January 29, 2024
Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report
Ruoxin Fang, Sha Xu, Jun Gong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 22, 2026
UBE2O Drives Immune Evasion and Radioimmunotherapy Resistance in Lung Cancer by Degrading CDKL1 to Induce PD-L1 Transcription
Huichan Xue, Xiaohua Jie, Zhiwei Liu, et al.
Redox Biology
|
September 14, 2025
Artesunate induces ferroptosis in gastric cancer by targeting the TFRC-HSPA9 axis for iron homeostasis regulation
Yi Liu, You Yu, Zhihong Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 8, 2026
PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer
Yunshang Chen, Zilong Wu, Yongqiang Yang, et al.
Frontiers in Immunology
|
September 10, 2024
Unraveling the obesity paradox in small cell lung cancer immunotherapy: unveiling prognostic insights through body composition analysis
Ruoxin Fang, Ling Yan, Sha Xu, et al.
Biochemical and Biophysical Research Communications
|
March 7, 2026
Quantitative analysis of ternary complex kinetics by a surface immobilization method
Xiaohan Mai, Yang Luo, Ruoxin Fang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Frontiers in Oncology
|
May 19, 2023
Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy
Ruoxin Fang, Ling Yan, Zhengkai Liao
Frontiers in Oncology
|
August 7, 2023
An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAF<sup>V600E</sup> mutation responds to dabrafenib and trametinib: a case report and literature review
Ruoxin Fang, Jun Gong, Zhengkai Liao
Oncotargets and Therapy
|
January 29, 2024
Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report
Ruoxin Fang, Sha Xu, Jun Gong, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
June 22, 2026
UBE2O Drives Immune Evasion and Radioimmunotherapy Resistance in Lung Cancer by Degrading CDKL1 to Induce PD-L1 Transcription
Huichan Xue, Xiaohua Jie, Zhiwei Liu, et al.
Redox Biology
|
September 14, 2025
Artesunate induces ferroptosis in gastric cancer by targeting the TFRC-HSPA9 axis for iron homeostasis regulation
Yi Liu, You Yu, Zhihong Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
July 8, 2026
PFKFB4 Deubiquitination by USP10 Enhances Fumarate Metabolism to Orchestrate the KDM1A/Rad51 Axis and Confer Radioresistance in Lung Cancer
Yunshang Chen, Zilong Wu, Yongqiang Yang, et al.
Frontiers in Immunology
|
September 10, 2024
Unraveling the obesity paradox in small cell lung cancer immunotherapy: unveiling prognostic insights through body composition analysis
Ruoxin Fang, Ling Yan, Sha Xu, et al.
Biochemical and Biophysical Research Communications
|
March 7, 2026
Quantitative analysis of ternary complex kinetics by a surface immobilization method
Xiaohan Mai, Yang Luo, Ruoxin Fang, et al.
Page
of 1